Posted in | News | Signal Processing

Raytheon Commences Production of 12th AN/TPY-2 Ballistic Missile Defense Radar

The U.S. is taking another positive step toward meeting the growing demand for systems that can help protect against the increasing danger posed by ballistic missiles. Raytheon Company has started building the 12th AN/TPY-2 ballistic missile defense radar for the Missile Defense Agency after being awarded a $172.7 million contract, which was previously announced by the Department of Defense on Dec. 17, 2013.

An integral element of the Ballistic Missile Defense System (BMDS), AN/TPY-2 is a mobile X-band radar that helps defend against the more than 6,300 ballistic missiles that, according to MDA estimates, are not controlled by the U.S., NATO, China or Russia.

"Beginning production of a 12th AN/TPY-2 ballistic missile defense radar is so important because this X-band sensor is the backbone of U.S. missile defense around the globe," said Dave Gulla, vice president of Global Integrated Sensors in Raytheon's Integrated Defense Systems business. "The U.S., our warfighters, allies and security partners can count on the AN/TPY-2 because it has performed flawlessly in every test to date against all categories of ballistic missiles."

About AN/TPY-2
AN/TPY-2 is a high resolution, mobile, rapidly deployable X-band radar capable of providing long-
range acquisition, precision track, and discrimination of short-, medium- and intermediate-range ballistic missiles. The AN/TPY-2 may be deployed globally in either terminal or forward-based mode. In terminal mode, the AN/TPY-2 serves as the search, detect, track, discrimination and fire-control radar for the THAAD weapon system, enabling the THAAD missile to intercept and destroy threats. In forward-based mode, the AN/TPY-2 cues the BMDS by detecting, discriminating and tracking enemy ballistic missiles in the ascent phase of flight.

  • On Oct. 25, 2012, two AN/TPY-2 radars – one terminal and one forward-based – participated in FTI-01, the MDA's largest and most complex exercise. In a complex raid scenario involving multiple targets, both radars met or exceeded all test objectives.
  • On April 15, 2011, a forward-based AN/TPY-2 extended the battlespace by enabling a Standard Missile-3 to launch on remote and intercept a separating Intermediate Range Ballistic Missile.
  • Raytheon has delivered eight AN/TPY-2s to the Missile Defense Agency. Some of those radars are currently helping defend the U.S. and its allies in the European, Pacific and Central Command area of responsibilities.

About Raytheon
Raytheon Company, with 2012 sales of $24 billion and 68,000 employees worldwide, is a technology and innovation leader specializing in defense, security and civil markets throughout the world. With a history of innovation spanning 91 years, Raytheon provides state-of-the-art electronics, mission systems integration and other capabilities in the areas of sensing; effects; and command, control, communications and intelligence systems; as well as a broad range of mission support services. Raytheon is headquartered in Waltham, Mass.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Raytheon Company. (2019, February 24). Raytheon Commences Production of 12th AN/TPY-2 Ballistic Missile Defense Radar. AZoSensors. Retrieved on July 24, 2024 from https://www.azosensors.com/news.aspx?newsID=7134.

  • MLA

    Raytheon Company. "Raytheon Commences Production of 12th AN/TPY-2 Ballistic Missile Defense Radar". AZoSensors. 24 July 2024. <https://www.azosensors.com/news.aspx?newsID=7134>.

  • Chicago

    Raytheon Company. "Raytheon Commences Production of 12th AN/TPY-2 Ballistic Missile Defense Radar". AZoSensors. https://www.azosensors.com/news.aspx?newsID=7134. (accessed July 24, 2024).

  • Harvard

    Raytheon Company. 2019. Raytheon Commences Production of 12th AN/TPY-2 Ballistic Missile Defense Radar. AZoSensors, viewed 24 July 2024, https://www.azosensors.com/news.aspx?newsID=7134.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.